Blood pressure adjustments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis

Haas, Sander de; Mulder, Enrique de; Schartmann, Niklas; Mohseni, Zenab; Hasson, Fatimah Abo; Alsadah, Fatimah; Kuijk, Sander van; Drongelen, J. van; Ghossein‐Doha, Chahinda; Spaanderman, Marc E. A.

doi:10.1016/j.preghy.2021.12.004

Cited by 12 publications

(7 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hurrell et al conducted a detailed review of blood pressure measurements in pregnant women [ 97 ]. A recent meta-analysis also confirmed that both systolic and diastolic blood pressure decrease by ~4 mmHg in the second trimester [ 98 ]; the results were very similar to those of a single cohort study investigating the use of home blood pressure [ 99 ].…”

Section: Blood Pressure Measurement During Pregnancysupporting

confidence: 64%

Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement

et al. 2022

View full text Add to dashboard Cite

Hypertensive disorders of pregnancy increase the risk of adverse maternal and fetal outcomes. In 2018, the Japanese classification of hypertensive disorders of pregnancy was standardized with those of other countries, and a hypertensive disorder of pregnancy was considered to be present if hypertension existed during pregnancy and up to 12 weeks after delivery. Strategies for the prevention of hypertensive disorders of pregnancy have become much clearer, but further research is needed on appropriate subjects and methods of administration, and these have not been clarified in Japan. Although guidelines for the use of antihypertensive drugs are also being studied and standardized with those of other countries, the use of calcium antagonists before 20 weeks of gestation is still contraindicated in Japan because of the safety concerns that were raised regarding possible fetal anomalies associated with their use at the time of their market launch. Chronic hypertension is now included in the definition of hypertensive disorders of pregnancy, and blood pressure measurement is a fundamental component of the diagnosis of hypertensive disorders of pregnancy. Out-of-office blood pressure measurements, including ambulatory and home blood pressure measurements, are important for pregnant and nonpregnant women. Although conditions such as white-coat hypertension and masked hypertension have been reported, determining their occurrence in pregnancy is complicated by the gestational week. This narrative review focused on recent reports on hypertensive disorders of pregnancy, including those related to blood pressure measurement and classification.

show abstract

Section: Blood Pressure Measurement During Pregnancysupporting

confidence: 64%

Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement

et al. 2022

View full text Add to dashboard Cite

show abstract

“…In normotensive pregnancy, SBP and DBP decrease compared with prepregnancy BP, attaining their maximum reduction of about 4 mmHg in the early second trimester with a gradual increase towards nonpregnant BP values in the last trimester. Healthy pregnancies seem to have lower SBP and DBP than previously assumed, namely less than 130/80 mmHg during the entire gestation, challenging the traditional, broader threshold for diagnosing gestational hypertension [38]. In a hypertensive pregnancy, SBP values may not be remarkably higher in the first part of gestation and may only lack the physiological decrease observed in normotensive pregnancy, and DBP may drop by 6 mmHg during the second trimester.…”

Section: Blood Pressure Measurements During Pregnancymentioning

confidence: 86%

Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group ‘Hypertension in Women’

Thomopoulos,

Hitij,

De Backer

et al. 2024

Journal of Hypertension

View full text Add to dashboard Cite

Hypertensive disorders in pregnancy (HDP), remain the leading cause of adverse maternal, fetal, and neonatal outcomes. Epidemiological factors, comorbidities, assisted reproduction techniques, placental disorders, and genetic predisposition determine the burden of the disease. The pathophysiological substrate and the clinical presentation of HDP are multifarious. The latter and the lack of well designed clinical trials in the field explain the absence of consensus on disease management among relevant international societies. Thus, the usual clinical management of HDP is largely empirical. The current position statement of the Working Group ‘Hypertension in Women’ of the European Society of Hypertension (ESH) aims to employ the current evidence for the management of HDP, discuss the recommendations made in the 2023 ESH guidelines for the management of hypertension, and shed light on controversial issues in the field to stimulate future research.

show abstract

“…Results = 5.176 means that obese pregnant women are 5.1 times more likely to suffer from hypertension compared to pregnant women who are not obese (Society for Maternal-Fetal Medicine & Publications Committee, 2022). Obesity is the percentage of fat abnormalities expressed by the body mass index, which compares body weight and height squared in meters (de Haas et al, 2022). Being overweight and having hypertension often go hand in hand because adding kilograms makes the heart work harder (Fakhouri et al, 2020).…”

Section: Figure 5 Progress Of Triglicerides Valuesmentioning

confidence: 99%

Nutrition Counseling, Lipid Profile Improvement and Weight Loss in Obese Patients with Dyslipidemia

Salman,

Hadi,

Ntau

et al. 2023

j. info kesehat.

View full text Add to dashboard Cite

Obesity with dyslipidemia is a serious problem because it risks various degenerative and metabolic diseases. The prevalence of obesity in Indonesia continues to increase every year, currently in the adult population reaching 21.8%. To prevent the onset of degenerative diseases and metabolic disorders, it is important to control obesity with dyslipidemia through weight loss and lipid profile improvement. This study aims to determine the effect of nutritional counseling in losing weight and improving lipid profiles in obese patients with dyslipidemia. This is a pseudo-experimental study with One group Pre and Post Test Design. The initial stage was the identification of obesity and lipid profile. In 100 respondents identified as obese, total cholesterol, LDL and triglycerides were examined. 40 obese respondents with dyslipidemia were determined as samples. The second stage was nutrition counseling intervention. The third stage of evaluation is the re-measurement of body weight and lipid profile. The research result is only 30 respondents participated in the evaluation. Average initial body weight was 75.11 kg and final body weight was 73.14 kg. Average weight loss was 1.97 kg. Average initial cholesterol 233.20 mg/dL and final cholesterol 224.70 mg/dL. Average cholesterol reduction of 8.5 mg/dL. Average initial LDL 152.37 mg/dL and final LDL 139.47 mg/dL. Average decrease in LDL 12.9 mg/dL Average initial triglycerides 161.23 mg/dL and final triglycerides 143.97 mg/dL. The average decrease in triglycerides is 17.26 mg/dL. The statistical test results showed a p-value = 0.000. There is an effect of nutritional counseling on weight loss and improvement of lipid profiles of obese patients with dyslipidemia.

show abstract

Blood pressure adjustments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis

Cited by 12 publications

References 42 publications

Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement

Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement

Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group ‘Hypertension in Women’

Nutrition Counseling, Lipid Profile Improvement and Weight Loss in Obese Patients with Dyslipidemia

Contact Info

Product

Resources

About